Loss of Heterozygosity in the MXI1 Gene Is a Frequent Occurrence in Melanoma

Melanoma development and progression is thought to be the result of a multi-step accumulation of genetic damage, with loss of heterozygosity in chromosome 9p (MTS1) frequently described. In addition, chromosome 10q allelic loss has been reported, implicating the tumor suppressor gene PTEN/MMAC1 on 10q23.3. The MXI1 gene at 10q24–25 is another candidate tumor suppressor that has only rarely been studied in melanomas, with conflicting results. We used microdissection-based genotyping to investigate 29 melanomas from 20 patients for loss of heterozygosity in intragenic and flanking microsatellite markers for this latter gene. Concurrently, the MTS1 gene was similarly studied using two flanking microsatellites. Fifty-four percent (15 of 28) of the informative cases showed loss of heterozygosity for one or both MXI1 markers, as compared with 67% (16 of 24) of the informative cases for MTS1. MXI1 allelic loss was seen more frequently in recurrent/metastatic tumors (59%), as compared with in primary (33%) lesions. Eighty percent of the primary tumors showed loss of heterozygosity for MTS1, as well as 63% of recurrent/metastatic ones. We studied more than one tumor in eight patients, with those from three patients showing discordant genetic patterns. One patient showed a metastatic tumor with allelic loss for MXI1 that was not identified in the primary melanoma or a local recurrence. The other two patients showed clonal heterogeneity in MXI1 at synchronous and metachronous metastatic foci. These findings support MXI1 as a putative tumor suppressor gene involved in conventional melanoma progression. Genetic heterogeneity seen in different metastases from the same primary suggests a nonlinear pattern of chromosomal damage, with the development of multiple clones within the primary tumor, each acquiring its own metastatic potential.

[1]  G. Finocchiaro,et al.  Redefinition of the coding sequence of the MXI1 gene and identification of a polymorphic repeat in the 3′ non-coding region that allows the detection of loss of heterozygosity of chromosome 10q25 in glioblastomas , 1995, Human Genetics.

[2]  X. Matías-Guiu,et al.  PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome. , 2002, The Journal of investigative dermatology.

[3]  R. Böni,et al.  Heterogeneity of allelic deletions within melanoma metastases , 2001, Melanoma research.

[4]  M. Wolter,et al.  Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas , 2000, Virchows Archiv.

[5]  P. Guldberg,et al.  Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. , 2000, The Journal of investigative dermatology.

[6]  M. Greene.  The genetics of hereditary melanoma and nevi , 1999, Cancer.

[7]  R. Herbst,et al.  PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo , 1999, Archives of Dermatological Research.

[8]  S. Finkelstein,et al.  Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  M. Takata,et al.  Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. , 1998, The Journal of investigative dermatology.

[10]  I. Jackson,et al.  Melanocortin 1 receptor variants in an Irish population. , 1998, The Journal of investigative dermatology.

[11]  E. Healy,et al.  Prognostic significance of allelic losses in primary melanoma , 1998, Oncogene.

[12]  S. Finkelstein,et al.  Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. , 1998, Human pathology.

[13]  A. Albino.  Genes involved in melanoma susceptibility and progression , 1995, Current opinion in oncology.

[14]  E. Healy,et al.  Loss of heterozygosity in sporadic primary cutaneous melanoma , 1995, Genes, chromosomes & cancer.

[15]  W. Cavenee,et al.  Loss of Heterozygosity for 10q22â€"lOqterin Malignant Melanoma Progression' , 1994 .

[16]  D. Elder,et al.  Chromosome 9 deletion in sporadic and familial melanomas in vivo. , 1994, Oncogene.